Lutonix Drug Coated Balloon
Payments companies reported to CMS as associated with Lutonix Drug Coated Balloon. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lutonix Drug Coated Balloon, per program year, as reported to CMS.
Who makes it
- Bard Peripheral Vascular, INC. $123K associated with Lutonix Drug Coated Balloon (2023-2025)
- Becton, Dickinson and Company $25K associated with Lutonix Drug Coated Balloon (2023-2025)
- Davol INC. $253 associated with Lutonix Drug Coated Balloon (2023-2025)
- C. R. Bard, INC. & Subsidiaries $142 associated with Lutonix Drug Coated Balloon (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lutonix Drug Coated Balloon
These are the largest totals companies reported as associated with Lutonix Drug Coated Balloon. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Phair | Long Island City, NY | Vascular Surgery | $1,571.60 |
| Christopher Smolock | Astoria, NY | Vascular Surgery | $1,501.36 |
| Vishal Kapur | New York, NY | Cardiovascular Disease | $1,256.78 |
| Alexander Ushinsky | Saint Louis, MO | Diagnostic Radiology | $1,150.61 |
| Ramesh Gowda | New York, NY | Interventional Cardiology | $1,079.29 |
| Kevin Engledow | San Antonio, TX | Vascular Surgery | $1,033.59 |
| John Danks | Paramus, NJ | Vascular Surgery | $985.73 |
| Brian Derubertis | New York, NY | Vascular Surgery | $976.46 |
| Alan Dietzek | Neptune, NJ | Vascular Surgery | $936.09 |
| Afshin Molkara | Loma Linda, CA | Surgery | $924.34 |
Prescribed Lutonix Drug Coated Balloon?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.